Dr Agarwals Eye Hospital Ltd

Dr Agarwal's Eye Hospital has announced its financial results for the quarter ending December 2024, showing a year-on-year sales growth of 25.23% to Rs 95.11 crore. However, rising interest expenses and a decline in profit before tax indicate challenges in managing financial stability and profitability.

Dr. Agarwals Eye Hospital, a small-cap entity in the Hospital & Healthcare Services sector, has recently experienced an evaluation adjustment. The company reported flat financial performance for the quarter ending September 2024, with notable metrics indicating a stable market position despite low mutual fund interest.

Dr Agarwals Eye Hospital's stock saw notable activity on February 13, 2025, with a significant increase, outperforming its sector. The stock opened higher and reached an intraday peak, while its recent performance has shown a positive trend over two days, despite challenges over the past month.

Dr Agarwals Eye Hospital's stock saw notable activity on February 12, 2025, rising after a seven-day decline. It reached an intraday high of Rs 3911.1, with significant volatility. Despite today's gains, the stock remains below key moving averages and has faced a substantial downturn over the past month.

Dr Agarwals Eye Hospital's stock has faced significant challenges, declining for seven consecutive days and dropping 21.24% during this period. The stock is trading below all key moving averages and has fallen 46.84% over the past month, contrasting with a minor decline in the broader market.

Dr Agarwals Eye Hospital's stock has faced significant challenges, declining for seven consecutive days and dropping 21.24% during this period. The stock is trading below all key moving averages and has fallen 46.84% over the past month, contrasting with a minor decline in the broader market.

Dr Agarwals Eye Hospital's stock has faced significant challenges, declining for seven consecutive days and dropping 21.24% during this period. The stock is trading below all key moving averages and has fallen 46.84% over the past month, contrasting with a minor decline in the broader market.

Dr Agarwals Eye Hospital has recently experienced a change in evaluation, reflecting various underlying trends. The company reported flat financial performance in Q2 FY24, with high interest expenses but a strong ability to service debt. Despite minimal mutual fund interest, it has shown consistent returns over three years, outperforming the BSE 500 index.

Dr Agarwals Eye Hospital's stock has faced significant declines, dropping 7.25% on February 7, 2025, and accumulating an 11.75% decrease over five days. The stock is trading below key moving averages and has fallen 40.55% in the past month, contrasting sharply with the more stable performance of the Sensex.

Dr Agarwals Eye Hospital's stock rebounded significantly on January 31, 2025, following a series of declines. The stock reached an intraday high of Rs 4849.95, showcasing notable volatility. Despite recent performance, it remains below several key moving averages while having declined over the past month.

Dr Agarwals Eye Hospital has faced notable stock volatility, experiencing a decline over three consecutive days and a significant drop in value over the past month. The stock's performance contrasts with the broader market, indicating challenges within the Hospital & Healthcare Services sector.

Dr Agarwals Eye Hospital has faced notable stock volatility, with a significant decline reported on January 27, 2025. The stock has dropped 15.22% over two days and 13.04% in the past month, underperforming compared to the broader market, indicating challenges in the current financial landscape.

Dr Agarwals Eye Hospital's stock has shown significant volatility, declining notably today after opening with a gap down. Despite a recent monthly gain, its one-day performance contrasts sharply with the broader market, indicating challenges within the Hospital & Healthcare Services sector. The stock's moving averages reflect mixed positioning.

Dr Agarwals Eye Hospital's stock surged significantly on January 14, 2025, outperforming both its sector and the broader market. Following a period of declines, the stock's strong performance is reflected in its trading above multiple moving averages, indicating a potential reversal in momentum.

Dr Agarwals Eye Hospital saw a significant decline on January 13, 2025, contributing to a two-day loss. Despite this, the stock outperformed its sector and remains above several moving averages. Over the past month, it has shown resilience, contrasting with broader market trends and sector challenges.

Dr Agarwals Eye Hospital has achieved an all-time high stock price of Rs. 7300, marking a significant milestone for the company. However, the stock has seen a revision in its score following a recent trend reversal, underperforming its sector despite impressive annual growth. The stock has been added to MarketsMOJO's list, reflecting its strong market position and performance indicators.

Dr Agarwals Eye Hospital has reached an all-time high stock price of Rs. 7300, marking a significant milestone for the small-cap healthcare provider. Despite this achievement, the stock has seen a revision in its score, reflecting recent market fluctuations. The company has been added to MarketsMOJO's list, highlighting its strong performance indicators and positive long-term trends.